Saini, V., Ammerman, N. C., Chang, Y. S., Tasneen, R., Chaisson, R. E., Jain, S., . . . Grosset, J. H. (2019). Treatment-Shortening Effect of a Novel Regimen Combining Clofazimine and High-Dose Rifapentine in Pathologically Distinct Mouse Models of Tuberculosis. Antimicrob Agents Chemother.
Citación estilo ChicagoSaini, Vikram, Nicole C. Ammerman, Yong Seok Chang, Rokeya Tasneen, Richard E. Chaisson, Sanjay Jain, Eric Nuermberger, y Jacques H. Grosset. "Treatment-Shortening Effect of a Novel Regimen Combining Clofazimine and High-Dose Rifapentine in Pathologically Distinct Mouse Models of Tuberculosis." Antimicrob Agents Chemother 2019.
Cita MLASaini, Vikram, et al. "Treatment-Shortening Effect of a Novel Regimen Combining Clofazimine and High-Dose Rifapentine in Pathologically Distinct Mouse Models of Tuberculosis." Antimicrob Agents Chemother 2019.